RVMD Smart Money
Revolution Medicines, Inc.
1W: -5.3%
1M: -7.7%
3M: +2.9%
YTD: +135.7%
1Y: +241.8%
3Y: +565.8%
5Y: +577.7%
$186.22
+2.32 (+1.26%)
Weekly Expected Move ±7.2%
$160
$174
$187
$201
$214
Credit Risk of going bust: lower than 73% of companies Debt: 1.6% of company value Bonds: $112.0M held by 36 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.29 (down 99.8%), Revolution Medicines, Inc. would be worth roughly what it owes.
Total debt $641.9M against a stock market value of $39.91B.
Distance to default 8.08 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $243.7M (short-term plus half of long-term), stock volatility 61.7%; Altman Z'' 1.52. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.29 (down 99.8%), Revolution Medicines, Inc. would be worth roughly what it owes.
Total debt $641.9M against a stock market value of $39.91B.
Distance to default 8.08 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $243.7M (short-term plus half of long-term), stock volatility 61.7%; Altman Z'' 1.52. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026763
Institutions Holding
+209 vs prior
100.0%
Ownership
+53.27%
248
New
241
Increased
208
Reduced
61
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Sandler Alan B. | officer: chief development officer | S-Sale | 301 | $204.72 | $62K | Filing |
| 2026-09-29 | Sandler Alan B. | officer: chief development officer | S-Sale | 1,199 | $203.91 | $244K | Filing |
| 2026-09-29 | Sandler Alan B. | officer: chief development officer | S-Sale | 1,000 | $202.81 | $203K | Filing |
| 2026-09-29 | Sandler Alan B. | officer: chief development officer | S-Sale | 1,609 | $201.72 | $325K | Filing |
| 2026-09-29 | Sandler Alan B. | officer: chief development officer | S-Sale | 2,200 | $200.82 | $442K | Filing |
| 2026-09-25 | Cislini Jeff | officer: svp & general counsel | S-Sale | 765 | $207.32 | $159K | Filing |
| 2026-09-25 | Mancini Anthony | officer: see remarks | S-Sale | 3,121 | $200.54 | $626K | Filing |
| 2026-09-24 | Mancini Anthony | officer: see remarks | S-Sale | 587 | $200.00 | $117K | Filing |
| 2026-09-22 | ANDERSON ELIZABETH M | director | S-Sale | 910 | $191.85 | $175K | Filing |
| 2026-09-22 | ANDERSON ELIZABETH M | director | S-Sale | 4,985 | $192.54 | $960K | Filing |
| 2026-09-22 | ANDERSON ELIZABETH M | director | S-Sale | 2,648 | $193.44 | $512K | Filing |
| 2026-09-22 | ANDERSON ELIZABETH M | director | S-Sale | 1,500 | $194.59 | $292K | Filing |
| 2026-09-22 | ANDERSON ELIZABETH M | director | S-Sale | 100 | $195.15 | $20K | Filing |
| 2026-09-18 | Mancini Anthony | officer: see remarks | S-Sale | 1,764 | $196.94 | $347K | Filing |
| 2026-09-16 | Cislini Jeff | officer: svp & general counsel | S-Sale | 3,314 | $199.30 | $660K | Filing |
| 2026-09-16 | Anders Jack | officer: chief financial officer | S-Sale | 61 | $195.00 | $12K | Filing |
| 2026-09-16 | Mancini Anthony | officer: see remarks | S-Sale | 27 | $195.05 | $5K | Filing |
| 2026-09-16 | GOLDSMITH MARK A | officer: see remarks | S-Sale | 13,775 | $199.30 | $2.7M | Filing |
| 2026-09-16 | GOLDSMITH MARK A | officer: see remarks | S-Sale | 213 | $195.01 | $42K | Filing |
| 2026-09-16 | Horn Margaret A | officer: chief operating officer | S-Sale | 4,891 | $199.30 | $975K | Filing |
| 2026-09-16 | Horn Margaret A | officer: chief operating officer | S-Sale | 76 | $195.01 | $15K | Filing |
| 2026-09-16 | Kelsey Stephen Michael | officer: see remarks | S-Sale | 5,484 | $199.30 | $1.1M | Filing |
| 2026-09-16 | Kelsey Stephen Michael | officer: see remarks | S-Sale | 85 | $195.01 | $17K | Filing |
| 2026-09-16 | Sandler Alan B. | officer: chief development officer | S-Sale | 336 | $199.30 | $67K | Filing |
| 2026-09-16 | Sandler Alan B. | officer: chief development officer | S-Sale | 5 | $194.96 | $975 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,695,790 | $2.6B | +2,483,084 | 2026-06-30 | Filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 13,550,796 | $2.5B | -54,000 | 2026-06-30 | Filing |
| FMR LLC | 12,200,422 | $2.3B | +3,736,108 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 11,443,357 | $2.1B | +1,888,000 | 2026-06-30 | Filing |
| Darwin Global Management, Ltd. | 10,629,822 | $2.0B | +8,418,804 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 10,736,145 | $2.0B | +10,736,145 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 9,088,661 | $1.7B | +726,377 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8,294,855 | $1.6B | +792,232 | 2026-06-30 | Filing |
| Nextech Invest Ltd. | 7,601,087 | $1.4B | — | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 6,361,323 | $1.2B | -294,380 | 2026-06-30 | Filing |
| UBS Group AG | 5,448,364 | $1.0B | +1,061,573 | 2026-06-30 | Filing |
| STATE STREET CORP | 4,897,051 | $917M | +494,389 | 2026-06-30 | Filing |
| Capital World Investors | 4,008,244 | $751M | +4,008,244 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,942,676 | $737M | +604,534 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 3,843,415 | $720M | -2,184,404 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 3,298,066 | $637M | +2,996,673 | 2026-06-30 | Filing |
| BVF INC/IL | 2,965,160 | $555M | +108,378 | 2026-06-30 | Filing |
| Alphabet Inc. | 2,946,619 | $552M | -345,906 | 2026-06-30 | Filing |
| Casdin Capital, LLC | 2,577,333 | $483M | — | 2026-06-30 | Filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,392,000 | $448M | +95,000 | 2026-06-30 | Filing |